Fiserv's Volume Surges 42% to $690M, Ranks 158th in Volume as Legal Scrutiny Over Clover Platform Intensifies

On September 8, 2025, Fiserv (NYSE: FI) closed at a 0.12% gain, with a trading volume of $690 million—up 42.47% from the prior day—ranking it 158th in volume among listed stocks. The move follows ongoing legal scrutiny over alleged misrepresentations related to its Clover payment platform.

Multiple law firms, including The Gross Law Firm and Pomerantz LLP, have filed class action lawsuits accusing Fiserv of misleading investors during the period from July 24, 2024, to July 22, 2025. The allegations center on forced transitions of Payeezy merchants to the Clover platform, which temporarily inflated growth metrics while concealing declining new business and merchant attrition. These practices allegedly masked unsustainable revenue trends, leading to significant share price declines in April and May 2025 after Fiserv revised guidance and disclosed slowing growth.

Berger Montague PC is also investigating similar claims, with a September 22, 2025, deadline for investors to seek lead plaintiff status. The lawsuits highlight concerns over Fiserv’s corporate governance and transparency, potentially impacting investor confidence amid broader market volatility in financial technology sectors.

To run this back-test robustly I need to pin down a few practical details that aren’t yet specified: 1. Market universe • Do you want U.S. listed equities only, or a global universe? • Should we exclude micro-caps, ADRs, ETFs, etc.? 2. Daily volume ranking rule • Rank on today’s volume at the close, buy the same close, and exit at tomorrow’s close (i.e., one-day holding period, close-to-close)? • Portfolio weighting: equal-weight across the 500 names, or volume-weighted / market-cap-weighted? 3. Execution & costs • Slippage / commission assumptions (if any). • Whether to allow stocks that go limit-up/limit-down, corporate actions handling, etc. 4. Benchmark (optional) • What index or reference should we compare the strategy against? Because the platform’s pre-built single-ticker back-testing tools don’t natively handle a 500-stock rebalancing portfolio, I’ll build the strategy in a multi-asset back-test framework once the above parameters are confirmed. Please let me know your preferences on these items, and I’ll proceed to construct the test.